| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 191 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 2652 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 3580 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 5023 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 6135 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 6975 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 7300 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 7976 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 11968 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 12222 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 14475 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 16050 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 18325 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 19100 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 23135 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 27440 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 32997 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 33533 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 35195 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 40536 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 48150 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 48241 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49457 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51334 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51850 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51993 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 52039 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 52123 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 54234 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 54831 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 55740 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 56164 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 56582 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 57370 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 61810 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 71700 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 77869 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 79258 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 83893 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 93354 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 98439 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 99886 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 101291 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 104896 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 113250 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 125774 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 136795 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 147498 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 162332 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 163455 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 179597 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 184265 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 227134 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 348612 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|